171 related articles for article (PubMed ID: 1627191)
1. Direct membrane-damaging effect of sertaconazole on Candida albicans as a mechanism of its fungicidal activity.
Agut J; Palacín C; Salgado J; Casas E; Sacristán A; Ortiz JA
Arzneimittelforschung; 1992 May; 42(5A):721-4. PubMed ID: 1627191
[TBL] [Abstract][Full Text] [Related]
2. Inhibition of ergosterol synthesis by sertaconazole in Candida albicans.
Agut J; Palacín C; Sacristán A; Ortiz JA
Arzneimittelforschung; 1992 May; 42(5A):718-20. PubMed ID: 1627190
[TBL] [Abstract][Full Text] [Related]
3. In vitro comparative study of the fungistatic and fungicidal activity of sertaconazole and other antifungals against Candida albicans.
Palacín C; Sacristán A; Ortiz JA
Arzneimittelforschung; 1992 May; 42(5A):711-4. PubMed ID: 1627188
[TBL] [Abstract][Full Text] [Related]
4. In vitro antifungal activity of sertaconazole.
Drouhet E; Dupont B
Arzneimittelforschung; 1992 May; 42(5A):705-10. PubMed ID: 1627187
[TBL] [Abstract][Full Text] [Related]
5. In vitro activity of sertaconazole.
Palacín C; Sacristán A; Ortiz JA
Arzneimittelforschung; 1992 May; 42(5A):699-705. PubMed ID: 1627186
[TBL] [Abstract][Full Text] [Related]
6. Suppression of ATP in Candida albicans by imidazole and derivative antifungal agents.
Odds FC; Cheesman SL; Abbott AB
Sabouraudia; 1985 Dec; 23(6):415-24. PubMed ID: 3913012
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and antimycotic activity of (benzo[b]thienyl)methyl ethers of 1-(2,4-dichlorophenyl)-2-(1H-imidazol-1-yl)-ethanol and of (Z)-1-(2,4-dichlorophenyl)-2-(1H-imidazol-1-yl)ethanone oxime.
Raga MM; Moreno-Mañas M; Cuberes MR; Palacín C; Castelló JM; Ortiz JA
Arzneimittelforschung; 1992 May; 42(5A):691-4. PubMed ID: 1627184
[TBL] [Abstract][Full Text] [Related]
8. [Cytological study of the action of imidazoles on Candida albicans (author's transl)].
Bastide M; Jouvert S; Bastide JM
Pathol Biol (Paris); 1982 Jun; 30(6):458-62. PubMed ID: 7050853
[TBL] [Abstract][Full Text] [Related]
9. Study on the sensitizing capacity of the new antimycotic sertaconazole in the treatment of cutaneous mycoses.
Romaguera C; Herrero E; Márquez M; Torres J; Ortiz JA
Arzneimittelforschung; 1992 May; 42(5A):754-6. PubMed ID: 1627200
[TBL] [Abstract][Full Text] [Related]
10. Plasma membrane damage to Candida albicans caused by chlorine dioxide (ClO2).
Wei MK; Wu QP; Huang Q; Wu JL; Zhang JM
Lett Appl Microbiol; 2008 Aug; 47(2):67-73. PubMed ID: 18624985
[TBL] [Abstract][Full Text] [Related]
11. Phytosphingosine kills Candida albicans by disrupting its cell membrane.
Veerman EC; Valentijn-Benz M; van't Hof W; Nazmi K; van Marle J; Amerongen AV
Biol Chem; 2010 Jan; 391(1):65-71. PubMed ID: 19919184
[TBL] [Abstract][Full Text] [Related]
12. Phase II study of the therapeutic efficacy and safety of the new antimycotic sertaconazole in the treatment of superficial mycoses caused by Candida albicans.
Umbert P; Nasarre J; Bello A; Herrero E; Roset P; Márquez M; Torres J; Ortiz JA
Arzneimittelforschung; 1992 May; 42(5A):757-60. PubMed ID: 1627201
[TBL] [Abstract][Full Text] [Related]
13. Multi-centre double-blind trial on the efficacy and safety of sertaconazole 2% cream in comparison with miconazole 2% cream on patients suffering from cutaneous mycoses.
Alomar C; Bassas S; Casas M; Crespo V; Ferrándiz C; Fonseca E; Hernández B; Noguera J; Pedragosa R; Peyrí J
Arzneimittelforschung; 1992 May; 42(5A):767-73. PubMed ID: 1627204
[TBL] [Abstract][Full Text] [Related]
14. The action of miconazole of the growth of Candida albicans.
Van Den Bossche H; Willemsens G; Van Cutsem JM
Sabouraudia; 1975 Mar; 13 Pt 1():63-73. PubMed ID: 1091999
[TBL] [Abstract][Full Text] [Related]
15. Direct membrane-damaging effect of ketoconazole and tioconazole on Candida albicans demonstrated by bioluminescent assay of ATP.
Anséhn S; Nilsson L
Antimicrob Agents Chemother; 1984 Jul; 26(1):22-5. PubMed ID: 6089651
[TBL] [Abstract][Full Text] [Related]
16. [Comparative action of 8 azole derivatives against Candida albicans: fungistatic action and cytologic study by scanning electron microscopy].
Mallie M; Jouvert S; Bastide M; Montes B; Lebecq JC; Bastide JM
Pathol Biol (Paris); 1988 May; 36(5):575-80. PubMed ID: 3043361
[TBL] [Abstract][Full Text] [Related]
17. Alterations produced by sertaconazole on the morphology and ultrastructure of Candida albicans.
Guarro J; Figueras MJ; Cano J
Mycoses; 1989 Jun; 32(6):283-95. PubMed ID: 2674712
[TBL] [Abstract][Full Text] [Related]
18. Therapeutic efficacy and safety of the new antimycotic sertaconazole in the treatment of cutaneous dermatophytosis.
Pedragosa R; González B; Martín M; Herrero E; Roset P; Márquez M; Torres J; Ortiz JA
Arzneimittelforschung; 1992 May; 42(5A):760-3. PubMed ID: 1627202
[TBL] [Abstract][Full Text] [Related]
19. In vivo activity of sertaconazole in experimental dermatophytosis in guinea pigs.
Palacín C; Sacristán A; Ortiz JA
Arzneimittelforschung; 1992 May; 42(5A):714-8. PubMed ID: 1627189
[TBL] [Abstract][Full Text] [Related]
20. Pharmacokinetic evaluation of labelled sertaconazole after dermal application.
Agut J; Moren M; Rego M; Sacristán A; Ortiz JA
Arzneimittelforschung; 1992 May; 42(5A):748-51. PubMed ID: 1627198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
